(WAOW) � The U (FDA) has expanded the  emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine.
It is now approved for adolescents 12-15 years of age.
Pfizer was the first vaccine approved in the fight against the COVID-19 pandemic, back in December of 2020.
The Food and Drug Administration said Monday the shot is safe and offers strong protection for younger teens based on testing of more than 2,000 U.S. volunteers. Shots could begin soon once a federal vaccine panel issues recommendations for using the vaccine in 12- to 15-year-olds.
Vaccinating children of all ages will be critical to a return to normalcy. Most vaccines rolling out worldwide have been authorized for adults.
The latest news is welcome for U.S. families struggling to decide what activities are safe to resume when only the youngest family members remain unvaccinated.
Acting FDA Commissioner Janet Woodcock, M.D., made the following statement on the expansion.
“The FDA’s expansion of the emergency use authorization for the Pfizer-BioNTech COVID-19 Vaccine to include adolescents 12 through 15 years of age is a significant step in the fight against the COVID-19 pandemic,� said Acting FDA Commissioner Janet Woodcock, M.D. “Today’s action allows for a younger population to be protected from COVID-19, bringing us closer to returning to a sense of normalcy and to ending the pandemic. Parents and guardians can rest assured that the agency undertook a rigorous and thorough review of all available data, as we have with all of our COVID-19 vaccine emergency use authorizations.�
Coronavirus Resources
- Are you fully vaccinated? for guidance from the CDC.
- Â for the latest information from the Illinois Department of Public Health.
- Looking for local information on the COVID-19 vaccine? .
- for News 3 WSIL's latest coronavirus coverage.